Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis

INTRODUCTION: Late stage clinical trials in non-alcoholic steatohepatitis (NASH) are currently required by the FDA to use liver biopsy as a primary endpoint. The well-reported limitations with biopsy, such as associated risks and sampling error, coupled with patient preference, are driving investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Dennis, Andrea, Kelly, Matt D., Fernandes, Carolina, Mouchti, Sofia, Fallowfield, Jonathan A., Hirschfield, Gideon, Pavlides, Michael, Harrison, Stephen, Chakravarthy, Manu V., Banerjee, Rajarshi, Sanyal, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877451/
https://www.ncbi.nlm.nih.gov/pubmed/33584535
http://dx.doi.org/10.3389/fendo.2020.575843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877451/
https://www.ncbi.nlm.nih.gov/pubmed/33584535
http://dx.doi.org/10.3389/fendo.2020.575843

Ejemplares similares